ASK REDCHAT ANYTHING ABOUT ORAMED PHARMACEUTICALS INC.
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP)
Listen to this Section
$3.82
+0.1650
(
+4.52% )
119.4K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| ORMD-0801 (ORA-D-013-1)DetailsDiabetes, Type 2 diabetes |
Phase 3 |
| ORMD-0801DetailsNon-alcoholic steatohepatitis , Liver disease |
Phase 2 |
Market Data
|
| Open |
$3.82 |
| Previous Close |
$3.65 |
| Volume |
119.4K |
| Market Cap |
$149.38M |
| Day Range |
$3.49 - $3.88 |
| 52 Week Range |
$1.98 - $5.01 |
| Shares Outstanding |
40.93M |
| Change % |
+4.52% |
| Net Change |
▲ 0.1650 |
| Insider Ownership |
-0.10% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2004 |
| Country | Israel |
Insider Ownership Transactions
Total Amount Purchased:
-1,265,850.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-06-21 |
Sale |
-140040.00 |
Gabay Avraham |
| 2024-06-10 |
Sale |
-760.00 |
Reznick Yehuda |
| 2024-04-18 |
Sale |
-29800.00 |
Reznick Yehuda |
| 2024-01-30 |
Sale |
-3750.00 |
Aghion Daniel |
| 2024-01-08 |
Sale |
-30000.00 |
Rozov Yadin |
| 2024-01-08 |
Sale |
-30000.00 |
Sank Leonard |
| 2024-01-08 |
Sale |
-30000.00 |
Mayer Arie |
| 2024-01-08 |
Sale |
-180500.00 |
Hexter Joshua |
| 2024-01-08 |
Sale |
-329000.00 |
KIDRON NADAV |
| 2024-01-08 |
Sale |
-295500.00 |
Kidron Miriam |